Skinvisible Web Sign Up for Updates         T 702.433.7154   |   F 702.548.4748
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.

Investor Overview

NEW - - - SKVI Now Trading Exclusively on OTCQB

Beginning February 22, 2011 Skinvisible (SKVI) will be quoted exclusively on the new OTCQB with an icon reading, "OTCQB -- U.S. Registered."

This new designation is used for OTC-traded companies that are U.S. registered and reporting. The OTCQB will help investors easily identify SEC reporting companies such as Skinvisible that are current with their disclosure obligations. As of February 18, 2011, market makers that previously traded Skinvisible on the OTCBB began exclusively trading Skinvisible on the new OTCQB. We do not believe it necessary at this time to reapply for quotation on the OTCBB because of the new trend in trading on the OTCQB.

To get a SKVI quote today, click here:

IMPORTANT: The OTCQB inter-dealer quotation system is interlinked with most financial websites but we encourage you to look at other sites if you do not see a current quote. All financial websites should be up-to-date in the near future.

Shareholder's Information:

Shares Outstanding Are: 117,001,969 (as of February 18, 2016)
Authorized: 200,000,000
Public Float: 56%
Insider Ownership: 44%
Fiscal Year End: December 31

July 7, 2017
Skinvisible Improves the Delivery of Cannabis with Patented Invisicare Technology - Topical and Transdermal Product Licensing Opportunities Available in the US and Globally

June 6, 2017
Skinvisible Completes First Sale of DermSafe Hand Sanitizer in China - Germ Protection Now Available to Millions of People in China

February 21, 2017
Skinvisible Brings Patented Technology to the Topical and Transdermal Cannabis Industry - Invisicare Delivery System to Enhance Medical and Recreational Marijuana Product Lines

September 15, 2016
Skinvisible Signs Global Licensing Agreement for Its Cannabis Products - Invisicare Enhances the Delivery of Topical Medical Marijuana in New Product Line


In the News:

Skinvisible featured in Drug Development & Delivery journal

Stock Information:

  SEC Filings
  SKVI quote
  Press Releases

Skinvisible Shareholder Update: 2015 in Review

Sign up for Skinvisible Inc. Updates: Click here to join our mailing list.
Home    |     About us    |    Technology    |    Products    |    Investors    |    Contact Us    |    Disclaimer & Privacy    |     Sign Up for Updates
© 2008 Skinvisible Pharmaceuticals, Inc.     Note: This website is not intended for Canadian residents.